chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after the shot, I had severe pain in my right hip joint. I've had bursitis in my hip except it's been many years since a flare up. I did have it last October after my 3rd vaccine but didn't think much of it. I didn't have any problems prior then when I got the shot, it was grief in my hip. I didn't think about it back with the 3rd vaccine and didn't mention it. I talked to Dr. and I'm taking diclofenac sodium and did that for 2 weeks and some physical therapy (exercises to do). He finally gave me a cortisone injection. I'm going in on Wednesday to probably get another injection and follow up. After the injection, everything was okay, and the pain went away. The pain diminished slowly within a day or so.
The patient is a 75 y male who was admitted on 12/2/2021 for chief complaint of left knee pain.   Patient had recent left knee arthroplasty on 11/30/21 and was discharged the following day.  He was initially doing well but then developed worsening pain and inability to stand or bear weight.  He has been taking Keflex since surgery.   Patient was found to be hypoxic in addition to being febrile at 101.4 F.  He underwent left lower extremity venous duplex that was negative for DVT.  Left knee x-ray showed no acute abnormalities without fracture and no evidence of loosening of the prosthesis.  CXR showed mild congestion. He was found to be positive for COVID-19. He states he had a negative COVID-19 test prior to his surgery. He notes he was fully vaccinated but did not receive his booster.   Patient was started on remdesivir, dexamethasone, vitamin C, vitamin D, and zinc for Covid-19. He was treated initially with IV diuretics for acute CHF and cardiology was consulted. His respiratory status improved and he was weaned to room air. Remdesivir and dexamethasone were discontinued early as he was no longer hypoxic. Diuretics were switched back to his home oral dose. He was evaluated by PT/OT and recommended post acute and will be discharged.
reaction began with a Metalic taste in mouth within 10 minthen  haziness, lip and throat swelling, tachycardia and high blood pressure I was given benadryl and when symptoms did not improve was taken to ER and given Decadron at 4:42pm then Famotidine and Sodium Chloride 0.9%
A LITTLE AFTER 24 HOURS, I HAD TIGHTNESS IN MY LOWER BACK AND SOME NUMBNESS IN MY LEFT LEG. THIS HAD SMILAR SYMPTOMS TO SCIATICA; WHICH I HAVE NEVER HAD AN OCCURRENCE.
fevers; pain in back; Diagnosed with pancreatitis/abdominal pain/She thought it was muscle pain; aches/She had the aches partially on Wednesday; chills; This is a spontaneous report from a contactable consumer (patient's husband). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm on 07Jun2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  Medical history included she was not on medications or anything else. She had no medical conditions.  She was otherwise healthy and she did not have any issues apart from knee surgery here and things you get when moving through age, nothing abnormal or noticeable. She does not drink. Historical vaccine included 1st dose of BNT162B2 for COVID-19 immunisation. Prior Vaccinations (within 4 weeks) If applicable, other vaccinations within four weeks prior to the first administration date of the suspect vaccines was none. The patient's concomitant medications were not reported. She went and got the second vaccine on Monday (07Jun2021) and had chills, aches, and all of those things that were associated with it.  She also had abdominal pain that came on as well.  She thought it was muscle pain. Caller stated this was on Tuesday night (08Jun2021), and then Wednesday night she went to the ER.  She was now diagnosed with pancreatitis.  Chills and aches: she got the shot and it started around 6 o'clock at night or 5 o'clock at night, somewhere around there which was about 6 hours afterwards.  After the second vaccine shot.  It was Monday 07Jun2021 she received it. Caller adds she was in the hospital right now.  Chills and aches, abdominal pain, pain in back, fever: they went away probably in the middle of the night between 08Jun2021 and 09Jun2021. So, she got the shot on 07JUN2021 around 6 o'clock and chills and aches through Tuesday. She had the aches partially on Wednesday 09Jun2021. At the end of the day, she felt better with the fever and aches but her pain was excruciating in the abdomen and back. Caller clarified this all started at the same time.  She thoughts it was muscle pain and not anything else going on. Caller adds the abdominal pain was still going on.  It was subsiding because they were kind of getting it under control but she was in a lot of pain right now. She was admitted yesterday morning (09Jun2021) around 3 or 4 o'clock, it was early, maybe 5 o'clock. Diagnosed with pancreatitis: it was the day she went in, was yesterday (09Jun2021). Investigations: she had lab blood work, ultrasound, MRI. Treatment, Investigations: caller stated pancreatitis does not have treatment besides managing the pain, the MRI and the ultrasound revealed no blockages or masses or cysts of organs, and no apparent cause of the pancreatitis. Outcome of the events was unknown.  Information for lot number has been requested.
Information has been received from a registered nurse referring to a 12 month old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 26-OCT-2016, the patient was vaccinated with a dose of VARIVAX (dose unknown, lot # M015731, expiration date: 30-MAR-2018, subcutaneously) in the right leg and PROQUAD (dose and route unknown, lot# M031566, expiration date: 24-DEC-2017) in left leg (overdose). The patient had not experienced an adverse effect. Additional information has been requested.
Sore arm, nausea, fever, diarrhea, tiredness, itchiness.
inappropriate schedule of vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced adverse event. The patient was treated with acyclovir. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The pharmacist stated that, it was for something that happened after receiving the 1st dose. The condition was unknown for what the patient was taking for the Acyclovir. At the time of reporting, the patient was taking Acyclovir. The patient was due for the 2nd dose of Shingrix. The reporter wanted to know, was it okay for them to receive the 2nd dose while they were taking Acyclovir, the patient would be taking it for a month. No additional information was available.
Syncopal episode without loss of consciousness. Was anxious before receiving injections. Immediately after last injected became very light-headed. We had him lie down and the symptoms went away. We put him in a sitting position at 10:16 am (BP normal 130/66, and standing position 10:17 BP normal 128/78 with no further symptoms. Left ambulatory to car with parent accompanied by a nurse with no further problems.
Patient described having cataplexy. Stated that they were at home and suddenly collapse onto the floor. They stated that for about 4 days they had profound muscle weakness and were not able to do anything.
My first vaccine was in April is it too late to get the second shot now?; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported. The treatment information was not provided.
vomiting; migraine; This case was reported by a consumer via call center representative and described the occurrence of vomiting in a 9-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2015-2016 season) (batch number 3L9LD, expiry date unknown) for prophylaxis.   In October 2015, the patient received Fluarix Quadrivalent 2015-2016 season. In October 2015, immediately after receiving Fluarix Quadrivalent 2015-2016 season, the patient experienced vomiting and migraine headache. On an unknown date, the outcome of the vomiting and migraine headache were recovered/resolved.   It was unknown if the reporter considered the vomiting and migraine headache to be related to Fluarix Quadrivalent 2015-2016 season.  Additional details were provided as follows: The age at vaccination was not reported. In October 2015, the patient received a Fluarix shot and almost immediately began to experience migraine and vomiting. The patient was taken to the emergency department and given an unspecified cocktail of migraine drugs via intravenous and released.  The patient had a follow up with a neurologist, an Magnetic resonance imaging was taken and nothing was found.  At time of this report, the migraine and vomiting resolved after 3 weeks post injection. The patient required emergency room Visit. The reporter consented to follow up.
This case was reported by a consumer and described the occurrence of tingling feet in an adult female subject who was vaccinated with HAVRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX, the subject experienced tingling feet. At the time of reporting the outcome of the event was unspecified. The consumer reported that she did not know if it was related to taking the vaccine. Additional information was provided regarding this case on 26 March 2008. The actual Hepatitis A vaccine received by the subject was not known (manufacturer unspecified). The subject was given Hepatitis A vaccine and experienced problems with her feet approximately 5 to 6 weeks later. She indicated that her doctor did not know the cause of her symptoms and she was not sure it was vaccine related. No additional details were provided.
Fever, chills, muscle spasms ,cramps,nausea, trouble forming thoughts, balance issues, lasting 48 hrs.
Chills, high fever, muscle pain, joint pain, fatigue, sore injection site, headache.
10:00 am on the 5th, I woke up and felt not very good. Tired and achy. I had  a fever that developed that day. I rested most of the day. Two days after that (about the 7th or so), I noticed that I had a rash on my right arm - elbow height (not injection site) - upper forearm. Not the bulls eye rash but just a rash and it itched super bad. I called the on-staff doctor because it was after hours. He said I could use cortisone cream on it to help with the itching. I also took some ibuprofen because I had the fever. The cream helped get rid of the rash within a couple of days. I still had the overall skin itchiness on my legs and stuff that I still had from the first vaccine - that overall itchiness had never gone away and I still had it. February 25, I woke up and I had some mild hives on my face and my eyelids were puffy and swollen and itchy (face was kind of itchy). I kept using the anti-itch lotion (from the first dose) and I quit taking my supplements to see if that would help. By the 26th, it was pretty bad. She prescribed me some steriods - methylprednisolone. She said if the hives left don't start it yet because she didn't want me to start it that night. So next morning, it wasn't horrible, so I didn't start taking them until March 1st and they are six day ones. It got pretty red and hived out and rashy  for a few days and the steriods seems to clear that by the six days. So by the 7th it was almost gone and by the 8th was all gone. It feels like the other itchiness is gone, too. The lymph node under my left arm, I thought had gone away but now a couple of weeks ago it felt like it came back and it still is feeling a little swollen.
1. Baseball size swelling in arm pit on arm where shot was given. 2. Numbness of left foot that lasted for 4 hours on day of shot and intermittently since Saturday but able to walk without issues.
About 5pm I started feeling nauseous,  beginning to throw up everything for the next two days I tried to eat or drink. I had a fever of 102 along with a horrible migraine,  body aches having to leave work up to two days after the shot to go home and sleep.
I had vertigo which I had never ever had before/I woke up and the room was spinning; My blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112; Little bit of swelling of my lips; Rash; This is a spontaneous report from a contactable consumer. A 70-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 21Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient on 12Mar2021 (19 days later) had vertigo which had never ever had before/ woke up and the room was spinning, on an unspecified date blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112, little bit of swelling of my lips, rash. Patient stated, patient do not have high blood pressure. Patient never had a vertigo before. Patients diastolic blood pressure has never ever gone to over 90. Systolic has never ever even at the worst situations gone over 160. Will that be related to the vaccine she wanted to know. The patient underwent lab tests and procedures which included blood pressure measurement: 136/78 (My blood pressure at the most goes maybe once in a while to 148 but generally probably 136/78 something like that), blood pressure measurement was 160 an hour later it was 180 and 2 hours later it was 205/112. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Myocarditis; This is a literature report for the following literature source(s):   A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1; Manufacturer unknown, ), for COVID-19 immunization. The following information was reported: MYOCARDITIS (hospitalization, medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: Echocardiogram: unknown result; Decreased LVEF, notes: in 3 cases; Rt. ventricular dysfunction, notes: in 3 cases; Echocardiogram: LVEF 33; Magnetic resonance imaging heart: unknown result; Enhancement, notes: pericardial in 3 cases; Enhancement (diffuse and global) with myocardial, notes: edema; T1: increased globalnative T1 value.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202201127030 Same article/drug/ event; different patient;US-PFIZER INC-202201127029 Same article/drug/ event; different patient.;
Uncontrolled shivering, fever 103.7 deg; sweats; lasted 8 hrs until fever broke; started 10 hrs after injection
This spontaneous report as received from a pharmacist refers to unspecified number of patients of unknown age and unknown gender. Patients concurrent conditions and relevant medical history was not reported. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot number, dose, frequency and route unspecified). Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with PNEUMOVAX 23 was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
After flu shot had weakness & temperature. Diagnosed 6 weeks later with dermatomyositis.
1 hour post vax, the pt developed redness, soreness and a small lump at the site of the injection on her left arm. It got worse and she couldn't move her arm. She developed chills and aches and the lump increased in size onto her shoulder. She took aspirin that day 2 times. The symptoms decreased.
Information has been received regarding a case in litigation from a lawyer concerning a male patient of an unknown age. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was inoculated with ZOSTAVAX (dose, route, lot number and expiration date were not reported) for routine health maintenance and for the prevention of shingles. On an unspecified date, the patient suffered tremors, followed by a numbness in his feet which then progressed up both legs. As a result of these symptoms, he presented to a medical provider and was diagnosed with ascending paresthesia and was treated with a 3 day of course intravenous immunoglobulin (IVIG) for presumed Guillain Barre Syndrome. Thereafter, he had continued to suffer the effects of his paresthesia. As a result, the patient had suffered and would continue to suffer significant medical expenses, pain and suffering, and other damages. The outcome of the Guillain Barre Syndrome was not recovered. The causal relationship between the event and ZOSTAVAX was related. Upon internal review, the event of Guillain Barre Syndrome was considered to be medically significant.
Patient seen in ED and transferred for inpatient admission where she was hospitalized for 3 days. ED notes:  Although patient alleges she can walk at home this seems very unlikely.  She was unable to even sit up on her own here.  Nurse had to help her get into the bed.  They had to help her even take her shirt off.  She seems very run down.  Complete blood count is normal.  Occult blood is negative.  COVID-19 is detected.  Temp here is 37.7.  Pulse ox 96%.  She is too weak to get an ambulatory sat on.  She has had 2 COVID vaccines.  CMP is relatively normal.  In talking her further she has been sick since December 18th.  She knows this because she saw her OB gyn doctor on the 17th and she was not sick that day and felt sick the next day.  This is day 8 of illness.  I will give her Decadron.  TSH normal.  BMP is normal.  I did contact Dr. for admission however just before she called back the troponin came back at 21. They will require 2nd troponin.  If the delta is less than 7 anticipate admission to Hospital.  Patient signed out to Dr.  Urinalysis and chest x-ray still pending.  Inpatient notes:  Patient is an 88 year female admitted for deconditioning s/p COVID 19. The patient is fully vaccinated. The patient presented to the ER for generalized fatigue and weakness which started on 12/17/2021. In the ED, CXR showed nonspecific patchy b/l airspace disease as seen with COVID. COVID testing was positive. The patient was not requiring oxygen. She was noted to be deconditioned and given inadequate home resources, was admitted for further evaluation and possible placement. PT/OT evaluated and recommended SAR. Patient refused and family felt it was ok for patient to return home with help from family. HHC was attempted to be arranged and no one would accept the patient. The patient was recommended to follow up with her PCP. She is high risk for readmission. She was discharged home in stable condition.
Wednesday, very painful left arm. Could not raise it above waist level without great pain. Went to bed and slept 15 hours. Got up achy all over. Headache. Took tylenol. Fever 101.5. Back to bed. Slept four hours. Got up and ate some toast. Very dizzy. Back to bed until next day, Friday, tired and headachy. By end of day felt quite sluggish and drained. Saturday still tired. Arm still hurt quite a bit. These symptoms lasted for a full week. (This was a full dose of Moderna)
Patient received a second bivalent booster after receiving their first on 9/16/2022. No adverse events occurred.
Redness, pain and swelling at site of injection. Diameter of swelling approx. 1.5 inches. Following day, swelling increased to 2.5 inches.
pt recv vax; devel fine raised rash across shoulders,upper chest & arms;using amish powder & cornstarch & is resolving;
Information has been received from a health care worker concerning a female who was vaccinated with GARDASIL vaccine (yeast). The health care worker reported that she heard from her professor that a girl had an "abnormal PAP smear" after getting GARDASIL vaccine (yeast). Additional information has been requested.
Lightheaded, feeling flushed, dizzy. Evaluated by ambulance.   3:05 pm feeling shaky.  Given snack, feeling better.  Discharged at 3:20 pm- symptoms resolved.
Developed syncope after vaccination and fell to floor.  History of near syncope with blood draws.  Later developed swollen upper lip..  Unclear if due to allergic reaction or traumatic when fell to the floor.  No rash, shortness of breath, throat tightness.  Felt light-headed with some nausea.  Symptoms resolved without treatment.
BODY ACHES/SHOOTING PAIN FROM FRONT OF HEAD TO BACK OF EARS/PAIN IN HANDS AND FEET; LETHARGIC; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body aches/shooting pain from front of head to back of ears/pain in hands and feet, lethargic, fever, headache, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, body aches/shooting pain from front of head to back of ears/pain in hands and feet, headache, nausea and lethargic was not reported. This report was non-serious. This case, from the same reporter is linked to 20210417271.